Qol Holdings CoTSE:3034 +1.57%87 Days Payable is 53.34 as of Mar. 2026, which is 9% above its 10-year median of 48.85. GuruFocus rates TSE:3034 with a GF Score™ of 87/100 and a GF Value™ of 円2,278.91 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 605 Healthcare Providers & Services companies, Qol Holdings Co ranks worse than 54.71% on this metric.
The historical rank and industry rank for Qol Holdings Co's Days Payable or its related term are showing as below:
TSE:3034'
s Days Payable Range Over the Past 10 Years
Min: 42.85 Med: 48.85 Max: 56.87
Current: 51.77
During the past 13 years, Qol Holdings Co's highest Days Payable was 56.87. The lowest was 42.85. And the median was 48.85.
TSE:3034's Days Payable is ranked worse than 54.71% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.51
vs TSE:3034: 51.77
Qol Holdings Co's Days Payable
declined
from Mar. 2025 (55.42) to Mar. 2026 (53.34).
It may suggest that Qol Holdings Coaccelerated paying its suppliers.
Qol Holdings Co Days Payable Related Terms
Qol Holdings Co Days Payable Historical Data
* Premium members only.
The historical data trend for Qol Holdings Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Qol Holdings Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co (TSE:3034) has a Days Payable of 53.34 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Qol Holdings Co and its competitors. This is near median its historical median of 48.85. Over the past decade, Qol Holdings Co's Days Payable has ranged from 42.85 to 56.87. According to the industry distribution chart, Qol Holdings Co ranks #331 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 54.7%.
Is Qol Holdings Co's Days Payable too high?
Qol Holdings Co's current Days Payable of 53.34 is near median its 10-year median of 48.85. Over the past 10 years, this metric has ranged from a low of 42.85 to a high of 56.87. The Healthcare Providers & Services industry median Days Payable is 57.51. Qol Holdings Co's value of 53.34 is 7.3% below this industry median. Based on the distribution chart, Qol Holdings Co ranks #331 out of 605 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Qol Holdings Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qol Holdings Co ranks #331 out of 605 companies for Days Payable. This places Qol Holdings Co in the lower half of its industry. The industry median Days Payable is 57.51. Qol Holdings Co's value of 53.34 is 7.3% below this benchmark. Historically, Qol Holdings Co's own Days Payable has ranged from 42.85 to 56.87 over the past decade. While the company's 10-year median is 48.85 vs. the industry median of 57.51, Qol Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.51, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qol Holdings Co's current Days Payable of 53.34 is 7.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Qol Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qol Holdings Co's current Days Payable is 53.34, which is near median its own 10-year median of 48.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,278.91, compared to a current price of 円1,937.00 — trading 15% below its estimated fair value. The current Days Payable is 53.34, which is near median its 10-year median of 48.85 and 7.3% below the Healthcare Providers & Services industry median of 57.51. Qol Holdings Co's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current Days Payable is 53.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qol Holdings Co (TSE:3034) Overvalued in 2026?
Based on GuruFocus' analysis, Qol Holdings Co stock appears to be undervalued.
The current stock price of 円1,937.00 is trading 15% below its estimated GF Value™ of 円2,278.91.
GuruFocus considers Qol Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:3034:
Days Payable: 53.34 (near median its 10-year median of 48.85)
GF Value™: 円2,278.91 vs. price of 円1,937.00 (15% below fair value)
Industry Position: 7.3% below the Healthcare Providers & Services median (#331 of 605)
No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
87GF Score
Get the complete analysis for TSE:3034
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3034 has been successfully added to your 
